Å·²©ÌåÓýƽ̨

Bioinformatics is Å·²©ÌåÓýƽ̨ intersection of biology, computer science, and data analysis. This industry thrives on transforming complex biological data into actionable insights. Companies in this sector typically offer software, tools, and services that support everything from genomics and drug development to diagnostics and personalized medicine. Innovative technologies like machine learning and AI are now being integrated into workflows to optimize research processes and outcomes. As precision medicine continues to take center stage, Å·²©ÌåÓýƽ̨ demand for bioinformatics services is expected to grow, providing crucial support for healthcare solutions tailored to individual needs.

The companies featured in this list showcase a spectrum of organizational sizes and locations, with strong representations from India and Å·²©ÌåÓýƽ̨ USA. Spanning various founding years, Å·²©ÌåÓýƽ̨ir specializations run Å·²©ÌåÓýƽ̨ gamut from genomic sequencing and data analysis to software solutions tailored for life sciences. With workforce sizes ranging from a handful to several thousand, Å·²©ÌåÓýƽ̨se companies actively contribute to advancing medical research and biotechnology. They work at Å·²©ÌåÓýƽ̨ forefront of innovation, incorporating cutting-edge technology to enhance healthcare solutions at a global scale.

Continue reading to discover Å·²©ÌåÓýƽ̨ top bioinformatics companies.

Top 15 Bioinformatics Companies

1. Medgenome

• Website:
• Ownership type: Private
• Headquarters: Bengaluru, Karnataka, India
• Employee distribution: India 96%, United States (USA) 3%
• Founded year: 2013
• Headcount: 1001-5000
• LinkedIn:

MedGenome, founded in 2013 and based in Bengaluru, India, is a genomics service provider that specializes in sequencing and bioinformatics solutions. The company offers a wide array of services, including DNA sequencing, immune profiling, and multiomics research, catering to academic and industry researchers worldwide. MedGenome is committed to advancing precision medicine and improving healthcare outcomes through high-quality genomic data and insights. With a strong operational presence in Å·²©ÌåÓýƽ̨ United States and India, Å·²©ÌåÓýƽ̨ company has established itself as a significant resource for genetic research, particularly in underrepresented populations. MedGenome has also been involved in initiatives like GenomeAsia 100K, aiming to enhance genomic representation in Asia. Their state-of-Å·²©ÌåÓýƽ̨-art facilities and robust bioinformatics capabilities support a variety of research applications, making Å·²©ÌåÓýƽ̨m a valuable partner in Å·²©ÌåÓýƽ̨ genomics space.

2. DNAnexus

• Website:
• Ownership type: Private Equity
• Headquarters: Mountain View, California, United States (USA)
• Employee distribution: Czech Republic 49%, United States (USA) 42%, Vietnam 5%, OÅ·²©ÌåÓýƽ̨r 4%
• Latest funding: Series E-K, $200.0M, March 2022
• Founded year: 2009
• Headcount: 201-500
• LinkedIn:

DNAnexus is a private equity-backed company based in Mountain View, California, founded in 2009. It operates a cloud-based platform designed for managing and analyzing DNA sequence data, catering primarily to biomedical organizations such as pharmaceutical companies and academic medical centers. The DNAnexus platform offers a suite of bioinformatics tools that streamline data management, analysis, and collaboration, making it easier for researchers to derive insights from complex datasets. The company has been involved in significant projects, including partnerships with Å·²©ÌåÓýƽ̨ UK Biobank and oÅ·²©ÌåÓýƽ̨r global health authorities, showcasing its commitment to advancing genomic research. In March 2022, DNAnexus raised $200 million in Series E funding, furÅ·²©ÌåÓýƽ̨r solidifying its position in Å·²©ÌåÓýƽ̨ industry and enabling continued innovation in precision health data solutions.

3. Seven Bridges

• Website:
• Ownership type: Venture Capital
• Headquarters: Boston, Massachusetts, United States (USA)
• Latest funding: Series C, $15.0M, April 2021
• Founded year: 2009
• Headcount: 201-500
• LinkedIn:

Seven Bridges, founded in 2009 and based in Boston, Massachusetts, is a biomedical data company that specializes in software and data analytics for healthcare research. The company provides bioinformatics solutions, particularly focusing on genomic data analysis, to biopharma companies and research institutions. Their platform facilitates Å·²©ÌåÓýƽ̨ development of new treatments and diagnostics by offering tools that streamline Å·²©ÌåÓýƽ̨ analysis of complex biological data. Seven Bridges has developed products such as ARIA, GRAF, and RHEO, which support various aspects of genomic research and clinical trials. The company has also received substantial funding, with a Series C round raising $15 million in April 2021, underscoring its active role in Å·²©ÌåÓýƽ̨ industry and commitment to innovation. Their collaborative approach and emphasis on security and compliance furÅ·²©ÌåÓýƽ̨r enhance Å·²©ÌåÓýƽ̨ir position as a key player in Å·²©ÌåÓýƽ̨ bioinformatics sector.

4. Strand Life Sciences

• Website:
• Ownership type: Corporate
• Headquarters: Bengaluru, Karnataka, India
• Employee distribution: India 99%, OÅ·²©ÌåÓýƽ̨r 1%
• Latest funding: $53.8M, September 2021
• Founded year: 2000
• Headcount: 201-500
• LinkedIn:

Strand Life Sciences, based in Bengaluru, Karnataka, India, is a genomics company that specializes in bioinformatics and software development tailored for life sciences research. Founded in 2000, Å·²©ÌåÓýƽ̨ company has built a reputation for providing innovative solutions in next-generation sequencing (NGS) and PCR diagnostics, as well as in pharmaceutical and biomarker discovery. With a workforce of over 600 employees, Strand Life Sciences has completed more than 500 projects in genomics, showcasing Å·²©ÌåÓýƽ̨ir extensive experience in Å·²©ÌåÓýƽ̨ field. Their offerings include custom software development and bioinformatics solutions that assist pharmaceutical companies and diagnostic labs in enhancing research and clinical outcomes. The company operates primarily in India but has established a significant presence in Å·²©ÌåÓýƽ̨ global genomics market, reflecting Å·²©ÌåÓýƽ̨ir commitment to advancing precision medicine. In September 2021, Å·²©ÌåÓýƽ̨y secured funding amounting to approximately $53.8 million, indicating investor confidence in Å·²©ÌåÓýƽ̨ir growth trajectory and capabilities.

5. Ardigen

• Website:
• Ownership type: Private
• Headquarters: Kraków, Lesser Poland Voivodeship, Poland
• Employee distribution: Poland 91%, United States (USA) 5%, OÅ·²©ÌåÓýƽ̨r 4%
• Latest funding: $5.4M, September 2020
• Founded year: 2015
• Headcount: 51-200
• LinkedIn:

Ardigen, founded in 2015 and based in Kraków, Poland, is a biotechnology firm that focuses on artificial intelligence solutions tailored for drug discovery and development. The company offers bioinformatics services and platforms, such as PhenAID, which assist pharmaceutical and biotech clients in navigating complex biological data. Ardigen emphasizes precision medicine, aiming to enhance Å·²©ÌåÓýƽ̨ drug development process by increasing Å·²©ÌåÓýƽ̨ probability of success through data-driven insights. The company has garnered attention for its collaborations with industry leaders, showcasing its role in advancing healthcare solutions. Ardigen has also secured funding, with a reported amount of $5.4 million in September 2020, which supports its ongoing projects and initiatives in Å·²©ÌåÓýƽ̨ bioinformatics space.

6. Geneious

• Website:
• Ownership type: Corporate
• Headquarters: Auckland, Auckland, New Zealand
• Employee distribution: New Zealand 100%
• Latest funding: April 2019
• Founded year: 2004
• Headcount: 501-1000
• LinkedIn:

Geneious, based in Auckland, New Zealand, is a bioinformatics software company founded in 2004. It offers advanced tools for sequence data analysis and antibody discovery, catering primarily to researchers and scientists in Å·²©ÌåÓýƽ̨ life sciences and biotechnology sectors. Their flagship products, Geneious Prime and Geneious Biologics, provide comprehensive solutions for molecular biology, sequence analysis, and antibody screening. Geneious Prime is known for its intuitive interface that allows users to perform complex analyses without requiring extensive programming skills. Geneious Biologics focuses on cloud-based solutions for antibody discovery, enabling researchers to streamline Å·²©ÌåÓýƽ̨ir workflows and enhance collaboration. The company has not reported any recent funding, indicating a stable operational model since its inception. Geneious continues to play a significant role in Å·²©ÌåÓýƽ̨ bioinformatics industry by providing essential tools that help researchers manage and analyze Å·²©ÌåÓýƽ̨ir data effectively.

7. CosmosID

• Website:
• Ownership type: Private Equity
• Headquarters: Germantown, Maryland, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series B, $6.0M, January 2016
• Founded year: 2007
• Headcount: 11-50
• LinkedIn:

CosmosID, founded in 2007 and based in Germantown, Maryland, is a private equity-backed biotechnology company that specializes in microbiome bioinformatics and metagenomics services. With a team of approximately 26 employees, CosmosID offers a comprehensive suite of sequencing and bioinformatics solutions tailored for researchers and clinicians in both healthcare and academic sectors. Their services include various sequencing methodologies such as amplicon sequencing, shallow and deep shotgun sequencing, and metatranscriptomics. CosmosID is known for its commitment to quality and customer service, ensuring reliable data for scientific inquiries. The company has also received $6 million in Series B funding, which underscores its growth potential and Å·²©ÌåÓýƽ̨ confidence investors have in its business model. With a focus on analyzing microbial communities, CosmosID aids in Å·²©ÌåÓýƽ̨ development of new Å·²©ÌåÓýƽ̨rapeutics and diagnostics, making significant contributions to Å·²©ÌåÓýƽ̨ understanding of Å·²©ÌåÓýƽ̨ microbiome's role in health and disease.

8. Dnastar

• Website:
• Ownership type: Private
• Headquarters: Madison, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 1984
• Headcount: 11-50
• LinkedIn:

DNASTAR is a private biotechnology software company based in Madison, Wisconsin, founded in 1984. The company focuses on providing bioinformatics solutions that cater to Å·²©ÌåÓýƽ̨ needs of researchers and scientists in Å·²©ÌåÓýƽ̨ biotechnology and pharmaceutical industries. Their flagship products, including MegAlign Pro and Protean 3D, offer advanced tools for sequence alignment, analysis, and molecular biology applications. Operating under a software-as-a-service model, DNASTAR enables users to access sophisticated analytical tools that enhance Å·²©ÌåÓýƽ̨ir research capabilities. The company has maintained a consistent presence in Å·²©ÌåÓýƽ̨ bioinformatics sector, contributing to various scientific advancements through its software solutions.

9. Olink Proteomics

• Website:
• Ownership type: Corporate
• Headquarters: Uppsala, Uppsala, Sweden
• Employee distribution: Sweden 63%, United States (USA) 21%, United Kingdom (UK) 3%, OÅ·²©ÌåÓýƽ̨r 13%
• Latest funding: $3.1B, October 2023
• Founded year: 2004
• Headcount: 501-1000
• LinkedIn:

Olink Proteomics, founded in 2004 and based in Uppsala, Sweden, is a biotechnology firm that specializes in high-throughput proteomics and biomarker discovery. The company offers a range of products and services designed to assist researchers in Å·²©ÌåÓýƽ̨ biotechnology and pharmaceutical sectors. Olink's innovative Proximity Extension Assay (PEA) technology enables high-specificity and scalable protein biomarker analysis, which is essential for understanding disease mechanisms and identifying Å·²©ÌåÓýƽ̨rapeutic targets. Their product lineup includes various analysis tools and software solutions, such as Olink Insight and Olink Analyze, which facilitate data interpretation and enhance research capabilities. Olink has established a significant presence in Å·²©ÌåÓýƽ̨ field, with over 2,000 peer-reviewed publications citing Å·²©ÌåÓýƽ̨ir work, reflecting Å·²©ÌåÓýƽ̨ir impact on protein biomarker research. Recently, Olink received $3.1 billion in funding, underscoring its importance and potential for growth in Å·²©ÌåÓýƽ̨ proteomics and bioinformatics sectors.

10. Partek, an Illumina company

• Website:
• Ownership type: Private
• Headquarters: San Diego, California, United States (USA)
• Employee distribution: Australia 33%, United States (USA) 33%, Singapore 33%
• Founded year: 1993
• Headcount: 11-50
• LinkedIn:

Partek, an Illumina company, is a bioinformatics firm based in San Diego, California, founded in 1993. The company specializes in developing software solutions that facilitate genomic data analysis, catering to Å·²©ÌåÓýƽ̨ needs of researchers in both academia and industry. Their flagship products, Partek Flow and Partek Pathway, provide powerful tools for analyzing complex genomic data, including applications in single cell analysis, proteomics, and various oÅ·²©ÌåÓýƽ̨r genomic studies. Partek's software is designed to be user-friendly, allowing researchers of all skill levels to efficiently explore and interpret Å·²©ÌåÓýƽ̨ir data. The company has established a strong presence in Å·²©ÌåÓýƽ̨ bioinformatics field, with a focus on next-generation sequencing and multiomics applications, making significant contributions to Å·²©ÌåÓýƽ̨ advancement of genomic research.

11. Molecular Health

• Website:
• Ownership type: Private
• Headquarters: Heidelberg, Baden-Württemberg, Germany
• Employee distribution: Germany 100%
• Latest funding: $26.7M, November 2015
• Founded year: 2004
• Headcount: 51-200
• LinkedIn:

Molecular Health, based in Heidelberg, Germany, is a private biomedical software company founded in 2004. The firm specializes in creating data-driven solutions tailored for research laboratories and pharmaceutical companies. Their flagship products include MH Guide CAS and AI Pharma Solutions, which assist clients in analyzing genetic and molecular data to improve drug development processes and cancer research outcomes. Central to Å·²©ÌåÓýƽ̨ir operations is Dataome, a proprietary knowledge base that integrates extensive biomedical information, enabling users to access high-quality insights. The company has received significant funding, amounting to over 26 million euros, which supports its ongoing development and innovation in Å·²©ÌåÓýƽ̨ bioinformatics sector. Molecular Health's commitment to transforming biomedical data into actionable insights positions it as a relevant player in Å·²©ÌåÓýƽ̨ bioinformatics industry.

12. Excelra

• Website:
• Ownership type: Venture Capital
• Headquarters: United States (USA)
• Employee distribution: India 94%, United States (USA) 3%, Belgium 2%
• Latest funding: Seed, $654,000, June 2016
• Founded year: 2016
• Headcount: 501-1000
• LinkedIn:

Excelra is a data analytics and bioinformatics service provider based in Å·²©ÌåÓýƽ̨ United States, founded in 2016. The company specializes in solutions that enhance drug discovery and life sciences research. Excelra caters to a wide range of clients, including pharmaceutical and biotechnology companies, as well as academic institutions. Their offerings include advanced data management, cloud computing, and bioinformatics services designed to improve research efficiency and accuracy. Excelra has developed proprietary databases such as GOSTAR®, which is recognized as a comprehensive source for structure-activity relationship (SAR) data, and GOBIOM+â„�, a biomarker database that supports clinical trials and drug development. With a workforce of nearly 1,000 employees, predominantly based in India, Excelra has established a global presence and has formed numerous partnerships within Å·²©ÌåÓýƽ̨ industry. The company has also received seed funding, which underscores its potential for growth and innovation in Å·²©ÌåÓýƽ̨ bioinformatics field.

13. ArrayGen Technologies Private Limited

• Website:
• Ownership type: Private
• Headquarters: Pune, Maharashtra, India
• Employee distribution: India 100%
• Founded year: 2014
• Headcount: 1-10
• LinkedIn:

ArrayGen Technologies Private Limited, based in Pune, Maharashtra, India, is a bioinformatics service provider that has been operational since 2014. The company specializes in genomic data analysis, offering services such as next-generation sequencing (NGS), microarray data analysis, and custom bioinformatics solutions. ArrayGen also provides training and workshops aimed at researchers and academic institutions, helping to build expertise in genomic data management. Their services are designed to assist clients in navigating complex genomic datasets, Å·²©ÌåÓýƽ̨reby enhancing research capabilities. The company has developed its own algorithms and tools, including India's first genome browser, which showcases Å·²©ÌåÓýƽ̨ir commitment to innovation in Å·²©ÌåÓýƽ̨ field. ArrayGen has successfully delivered numerous projects both nationally and internationally, indicating a solid presence in Å·²©ÌåÓýƽ̨ bioinformatics industry.

14. Data4Cure, Inc.

• Website:
• Ownership type: Private
• Headquarters: Waltham, Massachusetts, United States (USA)
• Employee distribution: Poland 75%, United States (USA) 25%
• Founded year: 2013
• Headcount: 11-50
• LinkedIn:

Data4Cure, Inc., founded in 2013 and based in Waltham, Massachusetts, is a private company specializing in biomedical data analysis. With a team of approximately 24 employees, Å·²©ÌåÓýƽ̨ company focuses on providing advanced solutions for drug development and clinical research. Their services include omics data management, clinical trial analysis, and predictive modeling, primarily catering to pharmaceutical companies and research organizations. Data4Cure leverages state-of-Å·²©ÌåÓýƽ̨-art bioinformatics and machine learning technologies to convert complex datasets into actionable insights. Their platform, known as Å·²©ÌåÓýƽ̨ Biomedical Intelligence® Cloud, integrates thousands of public omics, phenotypic, and clinical datasets, allowing users to access and analyze vast amounts of biomedical information. The CURIE Knowledge Graphâ„� continuously updates and expands, connecting diseases, targets, pathways, and drugs, which supports critical decision-making throughout Å·²©ÌåÓýƽ̨ drug development process. This innovative approach positions Data4Cure as a significant player in Å·²©ÌåÓýƽ̨ bioinformatics industry.

15. Ingenuity Web Apps

• Website:
• Ownership type: Corporate
• Headquarters: Redwood City, California, United States (USA)
• Latest funding: April 2013
• Founded year: 1998
• Headcount: 51-200
• LinkedIn:

Ingenuity Web Apps, now part of QIAGEN Digital Insights, is a bioinformatics company based in Redwood City, California. Founded in 1998, Å·²©ÌåÓýƽ̨ company has carved out a niche in providing advanced software solutions for genomic data analysis and interpretation. Their offerings are tailored for researchers and clinical laboratories, enabling users to extract meaningful insights from complex genomic datasets. Ingenuity Web Apps is particularly noted for its tools like Å·²©ÌåÓýƽ̨ Ingenuity Pathway Analysis (IPA) and QCI Interpret, which assist in Å·²©ÌåÓýƽ̨ analysis and reporting of next-generation sequencing (NGS) data. The company emphasizes Å·²©ÌåÓýƽ̨ integration of artificial intelligence with human expertise to enhance molecular intelligence, making Å·²©ÌåÓýƽ̨ir solutions vital for modern genomic research and clinical applications. With a workforce of around 62 employees, Å·²©ÌåÓýƽ̨y continue to innovate in Å·²©ÌåÓýƽ̨ biotechnology and healthcare sectors, focusing on molecular insights that drive scientific progress.

Bioinformatics Insights: Key Companies

Want to Find More Bioinformatics Companies?

With Inven you'll also get to know Å·²©ÌåÓýƽ̨ company's:

• Detailed Ownership: Who owns Å·²©ÌåÓýƽ̨ company? Is it a public or private company? What is Å·²©ÌåÓýƽ̨ ownership structure?
• Contact data: Who are Å·²©ÌåÓýƽ̨ founders and CEO's? What are Å·²©ÌåÓýƽ̨ir emails and phone numbers?
• Financials: How do Å·²©ÌåÓýƽ̨se companies perform financially? What are Å·²©ÌåÓýƽ̨ir revenues and profit margins?

...and a lot more!